ABACUS PARENTERAL DRUGS LIMITED-APDL is a recipient of the “Uganda Responsible Investment Mark of Excellence” and inducted in The 2021 Uganda TOP50 Responsible Investments Book of Records in appreciation and recognition of its contribution and commitment to attainment of Uganda Vision 2040 and the United Nations Sustainable Development Goals. Certified and inducted by Public Opinions which is the leading field based organization working towards attainment of Uganda Vision 2040 and the United Nations Sustainable Development Goals through Issues Corporate Performance Monitoring, Research, Public Awareness, Public Relations, Information Dissemination, Corporate Profiling, Corporate Branding, Training and mentorship, Investment Advisory,etc.
APDL is a state of the art manufacturing facility that seamlessly integrates hi-tech engineering services into the building design. From the exterior view, the 36 acre APDL campus exudes careful planning, the interiors of the facility reveal thoughtful and spot on detailing. The facility is designed with materials and finishes that allow ample natural light thus conserving energy and still maintain high cleanliness standards and minimize maintenance. The entire facility is designed to meet the CGMP requirements.
The facility has over 300 highly qualified and experienced personnel in their areas of operation and are responsible for running and managing the facility. Its Mission is to deliver affordable pharmaceutical products to our customers by continuously improving our state-of-the-art technology, people, processes product quality and availability.
- Abacus Pharma (A) Ltd
- Kiboko Enterprises Ltd
- Kiboko Financial Services Ltd
- Kiboko Group Of Companies
ABACUS PARENTERAL DRUGS LIMITED
Plot 114, Block 191, Kinga-Mukono
P.O.Box 31376, Kampala, Uganda
Tel: +256 417 100 700